An interventional study of Education and Psychosocial Skills in Pelvic Floor Disorder and Pelvic Floor Awareness, sponsored by Dartmouth-Hitchcock Medical Center. Terminated at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Supportive care
PI Left Institution
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 61 studies in Pelvic Floor Disorders with a site in United States — 12 open to participants now, 16 under way, none of them phase 3. Pelvic Floor Disorders · United States.
Among the 61 studies in Pelvic Floor Disorders with a site in United States, this one is the 39th largest by enrollment of the 50 interventional ones that give a count, is one of 5 that started in 2026, is one of 38 with no phase, and was the 58th registered.
212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.
Browse Pelvic Floor Disorders studies →12 of the 61 studies in Pelvic Floor Disorders with a site in United States are open now. Recruiting first, the newest first:
Cassandra Kisby · Sites in United States
Ages 21+ · Women only
University of Cincinnati · Sites in United States
Ages 18+ · Women only
Beth Israel Deaconess Medical Center · Sites in United States
Ages 18+ · Women only
Yale University · Sites in United States
Ages 18+ · Women only
University of Miami · Sites in United States
Ages 18–75 · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 27 Pelvic Floor Disorders studies recruiting now, 17 (63%) set no upper age limit and 10 (37%) stop at 75 or younger; none take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
61 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 16 is below the median of 64 across 148 interventional studies indexed under Pelvic Floor Disorders.
Median enrollment 57 across the 50 interventional studies, 133 across the 11 observational. Of the 38 that completed or were terminated, 15 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 61 have an industry lead sponsor. The 10 most frequent:
Dartmouth-Hitchcock Medical Center is the lead sponsor of 489 studies on the registry; 69 are open to participants now.
Of its 31 completed or terminated interventional studies of FDA-regulated products, 21 (68%) have results posted.
Dartmouth-Hitchcock Medical Center has 1 study filed under Pelvic Floor Disorders — fewer than ten, so there is no comparison to draw.
8 of the studies in Pelvic Floor Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07387315TriHealth Inc.A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections | 2026-11 |
| NCT06689891Yale UniversityVideo-Based Pelvic Floor Muscle Therapy | 2026-12 |
| NCT06111209Brigham and Women's HospitalThe Anabolic Effect of Testosterone on Pelvic Floor Muscles | 2026-12-31 |
| NCT06796985University of MiamiBotox for Chronic Pelvic Pain | 2027-03-22 |
| NCT06798311University of ChicagoReducing Disparities in Urinary Control Symptoms for Minority Women | 2027-05 |
Add all 8 to your calendar (.ics) → With an account.
Among the 61 studies in Pelvic Floor Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
There is a critical need for evidence-based programs that address the educational needs and psychosocial impact of childbirth-related pelvic floor injuries and conditions in an accessible format. The purpose of this pilot study is to develop, implement, and evaluate the feasibility, acceptability, and preliminary effectiveness of a manualized 6-session psychosocial skills and education group for individuals with birth-related pelvic floor injuries and conditions. This group-based approach integrates psychoeducation, pain science, cognitive-behavioral techniques, acceptance-based and mindfulness skills to enhance quality of life and coping skills for those managing these conditions.
This research study will test whether a virtual education and psychosocial skills group can provide valuable resources and skill-building for people living with these conditions. The findings from this pilot study will help us understand whether this type of program is feasible, acceptable, and potentially beneficial, and will inform refinement of the group protocol and study procedures in preparation for a future randomized controlled trial.
Interested participants are eligible to participate if they:
Exclusion Criteria:
6-session, virtual psychosocial education and skills group, for individuals with birth-related pelvic floor conditions
Behavioral: Education and Psychosocial Skills
Participants will attend a 6-session, virtual psychosocial education and skills group, for individuals with birth-related pelvic floor conditions. This is a non-randomized pilot feasibility study. All enrolled participants will receive the same group content, with assessments conducted at baseline (pre-group), brief surveys after each session, and immediately following group completion.
Feasibility - retention; number of participants who complete at least four out of six sessions
Time frame: Through study completion (average of 8 weeks)
Feasibility - time to complete recruitment (target N=16)
Time frame: Through recruitment completion
Feasibility of the Intervention Measure
4-item instrument measuring the feasibility of an intervention using a 5-point Likert scale, with higher scores reflecting higher feasibility. Score range: 1-5 (score represents mean of items).
Time frame: Post-test administered immediately after completing 6-week intervention
Acceptability - Participant ratings of content relevance and helpfulness
Time frame: Weekly for 6 weeks
Acceptability of the Intervention Measure
4-item instrument measuring the acceptability of an intervention using a 5-point Likert scale, with higher scores reflecting greater acceptability. Score range: 1-5 (score represents mean of items).
Time frame: Post-test administered immediately after completing 6-week intervention
Patient Health Questionnaire
9-item depression measure, with each item scored on a 4-point Likert scale. Score range: 0-27; higher scores reflect more severe depression symptoms.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
Perinatal Anxiety Screening Scale
31-item measure of perinatal anxiety, with each item scored on a 4-point Likert scale. Score range: 0-93; higher scores reflect more severe anxiety symptoms.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
Barkin Index of Maternal Functioning
20-item measure of maternal functioning, with each item scored on a 7-point Likert scale. Score range 0-120; higher total scores reflect higher functioning.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
University of Washington Self-Efficacy Scale
6-item measure of chronic condition-related self-efficacy, with each item scored on a 5-point Likert scale. Scores range from 6-30; higher scores reflect greater self-efficacy.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
Pelvic Floor Impact Questionnaire
21-item measure of pelvic floor symptom-related impact, with each item scored on a 4-point Likert scale. Validated scoring formula results in a total score range of 0-300; higher scores reflect more symptom-related quality of life impairment.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
Queensland Female Pelvic Floor Questionnaire
42-item measure of pelvic floor symptom severity and associated level of bother across four categories (bladder function, bowel function, prolapse symtoms, sexual function), with each item scored on a 4-point Likert scale. Scores for each domain range from 0-10; higher scores reflect greater symptom severity.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
Brief COPE Inventory
28-items measure of various coping strategies, each item scored on a 4-point Likert scale. Scale scores range from 1-4 (representing mean of items); higher scores on each subscale indicate greater use of that coping strategy.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
Female Self Advocacy Scale
Female Self-Advocacy in Cancer Survivorship Scale (language modified; cancer survivorship --\> pelvic floor symptom management); 20-item measure of health-related self-advocacy, with each item scored on a 6-point Likert scale. Scores range from 20-120; higher scores reflect greater self-advocacy.
Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention
Plan to share: Undecided — De-identified data may be shared upon request, pending updated data sharing agreement forms.
No publications or documents are linked to this record.
Ran from Feb 2026 to primary completion in May 2026, 3 months.
How these figures are worked out, and which studies are left out of them.
PI Left Institution
PI Left Institution
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dartmouth-Hitchcock Medical Center →